Neural Prostheses and Gait Performance: Model-Based Strategies
NCT ID: NCT00991406
Last Updated: 2019-08-09
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
9 participants
INTERVENTIONAL
2009-06-30
2016-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
FES research projects vary from simple investigations of the therapeutic effects of exercise on muscle function and skin health, to more complex studies of functional movements such as standing or walking.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Stimulation Combined With Powered Motorized Orthoses for Walking After Stroke
NCT04116671
Feasibility and Practice Characteristics of FNS and Gait Robot
NCT00508755
Stroke Gait Rehabilitation Using Functional Electrical Stimulation
NCT01668602
FES-induced Muscular Control of the Knee on Balance and Gait Retraining After a Stroke or a Cerebral Injury
NCT04381546
Cognitive & Motor Training After Stroke For Everyday Walking Restoration
NCT01160653
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Arm 1: FES
Case-control study: pre- and post-stimulation (FES).
FES
Surface stimulation to contract the muscles in the lower extremity
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
FES
Surface stimulation to contract the muscles in the lower extremity
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Unilateral hemiparesis with sufficient endurance and motor ability to ambulate \>30 feet continuously without an AFO requiring no more than 25% physical help
* Berg Balance Scale score \>23 without assistive devices
* Standing ankle dorsiflexion strength of \<4/5
* Foot-drop during ambulation with gait instability or inefficient gait defined as supervision need
* Possible use of physical assistance or assistive device (cane, walker)
* Evidence of foot-drop as seen by "dragging" or "catching" of affected toes during limb swing or circumducting affected limb
* Vaulting of the unaffected limb or hiking the affected hip to clear toes.
* Intact and electrically ex-citable lower motor neurons
* Ankle dorsiflexion to at least neutral while standing with electrical stimulation of common peroneal and tibial nerves without painful hypersensitivity to stimulation
* Adequate social support and stability
* Medically stable with intact skin in affected lower limb
* Willingness to comply during research procedures
* No systemic co-morbidities
* No history of potentially fatal cardiac arrhythmias i.e. ventricular tachycardia, supraventricular tachycardia and rapid ventricular response atrial fibrillation with hemodynamic instability
* No psychological problems or chemical dependency
* No acute medical complications such as depression or chronic anxiety requiring long term pharmacological therapy. Able-bodied controls must be of similar age, body mass and stature as those with hemiparesis and must be free of any medical and disabling orthopedic problems.
* Requires an ankle foot orthosis (AFO) to prevent knee flexion collapse in stance
* Excessive edema of affected extremity
* Absent sensation in affected limb
* History of potentially fatal cardiac arrhythmias such as ventricular tachycardia, supraventricular tachycardia, and rapid ventricular response, atrial fibrillation with hemodynamic instability
* Demand pacemakers or any implanted electronic systems
* Pregnancy
* Uncontrolled seizure disorder
* Ipsilateral lower limb lower motor neuron lesion
* Parkinson's disease
* Spinal cord injury
* Traumatic brain injury
* Multiple sclerosis
* Ankle plantar flexor contraction
* Severely impaired cognition and communication
* Painful hypersensitivity to neuromuscular stimulation of common peroneal nerve
* Knee hyperextension (genu recurvatum) that cannot be adequately corrected with peroneal nerve stimulation
* History of botulinum toxin to the lower extremity within the prior three months.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
VA Office of Research and Development
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Elizabeth C Hardin van den Bogert, PhD MS
Role: PRINCIPAL_INVESTIGATOR
Louis Stokes VA Medical Center, Cleveland, OH
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Louis Stokes VA Medical Center, Cleveland, OH
Cleveland, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
B4668-R
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.